KYTX
Kyverna Therapeutics, Inc.
6.20$
+0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -391.7% | -514.1% | – | – | – | |
| 10.4% | 15.0% | – | – | – | |
| 128.2% | 13.2% | – | – | – | |
| -79.4% | -147.0% | – | – | – | |
| 22.8% | 10.9% | – | – | – | |
| -22.8% | -200.7% | – | – | – | |
| -0.7% | -3.5% | – | – | – | |
| 1,282.2% | 169.1% | – | – | – | |
| 867.7% | -545.6% | – | – | – | |
| -414.5% | -525.0% | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.